Verona, NJ, United States of America

Silvano L Debarnardo

This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silvano L Debarnardo. Retrieved from https://idiyas.com/inventor/silvano-l-debarnardo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Silvano L Debarnardo: Innovator in Anti-Inflammatory Research

Introduction

Silvano L Debarnardo is a notable inventor based in Verona, NJ (US). He has made significant contributions to the field of anti-inflammatory substances, particularly through his innovative research on selectin inhibition. His work has the potential to impact the treatment of various selectin-mediated disorders.

Latest Patents

Debarnardo holds 1 patent for his invention titled "Methods and compositions for selectin inhibition." This patent focuses on novel compounds that act as antagonists of mammalian adhesion proteins known as selectins. The invention provides methods for treating selectin-mediated disorders, which include the administration of specific compounds defined in the patent.

Career Highlights

Throughout his career, Silvano L Debarnardo has been associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to explore and develop innovative solutions in the realm of anti-inflammatory treatments.

Collaborations

Debarnardo has collaborated with notable colleagues such as Neelu Kaila and Raymond T Camphausen. These collaborations have contributed to the advancement of research in the field of selectin inhibition and anti-inflammatory therapies.

Conclusion

Silvano L Debarnardo's contributions to the field of anti-inflammatory research through his patent on selectin inhibition highlight his role as an innovator. His work continues to pave the way for potential treatments that could benefit many individuals suffering from selectin-mediated disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…